Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Arcus Biosciences, Inc.
Arcus Biosciences, Inc.
Neomorph, Inc
Bristol-Myers Squibb
Xencor, Inc.
Nuvectis Pharma, Inc.
Psyence Australia Pty Ltd
Pfizer
Arcus Biosciences, Inc.
Tizona Therapeutics, Inc
A2 Biotherapeutics Inc.
Adela, Inc
HiberCell, Inc.
Elephas
Kura Oncology, Inc.
Elephas
Sichuan Baili Pharmaceutical Co., Ltd.
7 Hills Pharma, LLC
A2 Biotherapeutics Inc.
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Molecure S.A.
Aurigene Discovery Technologies Limited